EUVIMEDEUVIMED entdecken
Open Access

Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor

Yuwei Xu iD, Zhen Xiong, Peikang Zhang, Runyuan Wu, Cunzhen Li, Hui Guo iD, Ying Du, Xiaoxiao Zhu, Dongdong Fan, Hongzhe Fan, Yong Tian iD, Yun Chen iD und 1 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adt9645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Yuwei Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: Lymphocytes, Immunity, Innate, Gastrointestinal Microbiome, Intestinal Mucosa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate lymphoid cells (ILCs) play critical roles in innate immunity, epithelial barrier protection, and tissue homeostasis. However, the maintenance machinery of intestinal tissue residency of ILCs remains elusive. Here, we show that gut microbiota is necessary for the maintenance of intestinal tissue residency of ILCs. Microbiota metabolite taurodeoxycholic acid (TDCA) binds to P2Y10 receptor on ILCs to initiate downstream Ca 2+ and RhoA signaling pathways. TDCA-P2Y10 engagement induces Zfp414 transcription to prime expression of CD69 and integrin αE on ILCs, leading to intestinal residency of ILCs. Moreover, decreased levels of TDCA or P2Y10 deficiency abrogates the intestinal residency of ILCs, resulting in severer intestinal inflammation. Of note, TDCA administration can enhance intestinal tissue residency of ILCs and promote protection against intestinal inflammation. Thus, TDCA might be used as a potential drug to treat patients with inflammatory bowel disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphocytesImmunity, InnateGastrointestinal MicrobiomeIntestinal MucosaIntestinesAnimalsMiceHumansSignal TransductionMice, Inbred C57BLMice, KnockoutInflammatory Bowel Diseases

Autor:innen und Institutionen

  • State Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Wuxi; Department of Immunology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collabora…
  • Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, China.

ORCID-Profile: Yuwei Xu, Hui Guo, Yong Tian, Yun Chen, Zusen Fan

Zitieren

APA

Xu, Y., Xiong, Z., Zhang, P., Wu, R., Li, C., Guo, H., Du, Y., Zhu, X., Fan, D., Fan, H., Tian, Y., Chen, Y., & Fan, Z. (2025). Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor. Science Advances. https://doi.org/10.1126/sciadv.adt9645

Vancouver

Xu Y, Xiong Z, Zhang P, Wu R, Li C, Guo H, et al. Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor. Science Advances. 2025. doi:10.1126/sciadv.adt9645

BibTeX
@article{Xu2025,
  author = {Xu, Yuwei and Xiong, Zhen and Zhang, Peikang and Wu, Runyuan and Li, Cunzhen and Guo, Hui and Du, Ying and Zhu, Xiaoxiao and Fan, Dongdong and Fan, Hongzhe and Tian, Yong and Chen, Yun and Fan, Zusen},
  title = {Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt9645}
}
Kostenlos starten →